Halaven
Eribulin Mesylate
- Strength
- 0.5mg/ ml
- Manufacturer
- Eisai Co Ltd.
- Availability
- Available to source
Eribulin Mesylate 0.5mg/ ml — Injection, 1's Vial
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: HALAVEN by Eisai Inc. · Manufacturer: Eisai Co Ltd.. Indication & Dosage: HALAVEN (Eribulin Mesylate) is a prescription medicine used to treat metastatic or advanced breast cancer that has spread to other parts of the body and who have already received other types of anticancer medicines after the cancer has spread. HALAVEN manufactured by Eisai Co. Ltd in India. Eribulin Mesylate is given by injection under the skin as directed by the doctor. The dosage is based on patient's medical condition and response to treatment. Please Follow doctor's instructions carefully. Side Effects: The most common adverse reaction of Eribulin Mesylate are: Weakness or tiredness , hair loss, nausea , constipation. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
